Related Experiment Video
Updated: Aug 18, 2025

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
The Potential Role of R4 Regulators of G Protein Signaling (RGS) Proteins in Type 2 Diabetes Mellitus
Xiaohong Zhang1,2, Hongyan Lv3, Juan Mei1,2
1Shandong Collaborative Innovation Center for Diagnosis, Treatment and Behavioral Interventions of Mental Disorders, Institute of Mental Health, Jining Medical University, Jianshe South Road No.45, Rencheng District, Jining 272013, China.
Abstract:
Type 2 diabetes mellitus (T2DM) is a complex and heterogeneous disease that primarily results from impaired insulin secretion or insulin resistance (IR). G protein-coupled receptors (GPCRs) are proposed as therapeutic targets for T2DM. GPCRs transduce signals via the Gα protein, playing an integral role in insulin secretion and IR. The regulators of G protein signaling (RGS) family proteins can bind to Gα proteins and function as GTPase-activating proteins (GAP) to accelerate GTP hydrolysis, thereby terminating Gα protein signaling. Thus, RGS proteins determine the size and duration of cellular responses to GPCR stimulation. RGSs are becoming popular targeting sites for modulating the signaling of GPCRs and related diseases. The R4 subfamily is the largest RGS family. This review will summarize the research progress on the mechanisms of R4 RGS subfamily proteins in insulin secretion and insulin resistance and analyze their potential value in the treatment of T2DM.
Insights
Regulators of G protein signaling (RGS) proteins, particularly the R4 subfamily, are crucial for managing insulin secretion and resistance. Targeting RGS proteins offers a promising therapeutic strategy for type 2 diabetes mellitus (T2DM).
Area of Science:
- Biochemistry
- Endocrinology
- Pharmacology
Background:
- Type 2 diabetes mellitus (T2DM) arises from impaired insulin secretion and insulin resistance (IR).
- G protein-coupled receptors (GPCRs) are key regulators of insulin secretion and IR, making them therapeutic targets.
- Regulators of G protein signaling (RGS) proteins modulate GPCR signaling by accelerating GTP hydrolysis.
Purpose of the Study:
- To review the mechanisms of R4 RGS subfamily proteins in insulin secretion and IR.
- To analyze the therapeutic potential of R4 RGS proteins for T2DM treatment.
Main Methods:
- Literature review of research on RGS proteins and their role in T2DM.
- Analysis of RGS protein function as GTPase-activating proteins (GAPs) for Gα proteins.
- Examination of GPCR signaling pathways involved in insulin regulation.
Main Results:
- RGS proteins, especially the R4 subfamily, significantly influence the duration and magnitude of cellular responses to GPCR stimulation.
- R4 RGS proteins play a critical role in regulating both insulin secretion and insulin resistance.
- Modulating RGS protein activity presents a viable strategy for T2DM management.
Conclusions:
- The R4 RGS subfamily is integral to the physiological processes underlying T2DM.
- Targeting R4 RGS proteins holds significant therapeutic promise for developing novel T2DM treatments.
- Further research into RGS protein mechanisms can unlock new avenues for diabetes therapy.
Related Concept Videos
Activation and Inactivation of G Proteins
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Diabetes Mellitus: Type 2 and Gestational
GPCRs Regulate Adenylyl Cylase Activity
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

